Pacific View Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Pacific View Asset Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-120,230	Closed	-$3.55M	–	41
2019 Q2	$3.55M	Buy	120,230 +18,419	+18%	+$710K	3.85%	12
2019 Q1	$4.84M	Sell	101,811 -9,690	-9%	-$427K	5.03%	6
2018 Q4	$4.02M	Buy	111,501 +22,704	+26%	+$1.07M	4.73%	4
2018 Q3	$5.46M	Buy	88,797 +20,131	+29%	+$1.29M	4.35%	4
2018 Q2	$4.64M	Buy	68,666 +44,069	+179%	+$2.47M	3.67%	9
2018 Q1	$1.33M	Sell	24,597 -73,753	-75%	-$4.12M	1.01%	25
2017 Q4	$5.88M	Buy	+98,350	New	+$5.96M	3.9%	3

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Pacific View Asset Management's AERI Position: Q3 2019 in Review

Pacific View Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2019, closing a stake of 120,230 shares — an estimated $3.55M sold.

Pacific View Asset Management first reported a position in AERI in Q4 2017 and held it in 7 quarters. The position peaked at $5.88M in Q4 2017. 167 funds tracked by Wall St. Rank hold AERI as of Q3 2019.

Pacific View Asset Management reported no remaining Aerie Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Pacific View Asset Management sold 120,230 Aerie Pharmaceuticals shares in Q3 2019, an estimated $3.55M.
Pacific View Asset Management first reported a position in Aerie Pharmaceuticals in Q4 2017 and held it in 7 quarters.
Pacific View Asset Management's Aerie Pharmaceuticals position peaked at $5.88M in Q4 2017.
167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2019.

Based on Pacific View Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.